APO Research
Talk to an analyst

APO RESEARCH · REPORT

GABAB Receptor Agonists

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global GABAB Receptor Agonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025190 pages

Choose your research edition.

Industry ResearchGABAB Receptor Agonists Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal GABAB Receptor Agonists Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal GABAB Receptor Agonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GABAB Receptor Agonists Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal GABAB Receptor Agonists Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global GABAB Receptor Agonists market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for GABAB Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for GABAB Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GABAB Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for GABAB Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of GABAB Receptor Agonists include Xi'an Libang Pharmaceuticals, Xi'an Hanfeng Pharmaceuticals, Sun Pharma, Hemony Pharmaceutical, Sichuan Ren'an Pharmaceuticals, Novartis, Nanjing Haina Pharmaceutical, China Resources Double Crane Pharmaceuticals and Fuan Pharmaceutical Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global GABAB Receptor Agonists market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GABAB Receptor Agonists and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GABAB Receptor Agonists sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GABAB Receptor Agonists market size, projected growth trends, production technologies, key applications, and end-use industries.

GABAB Receptor Agonists Segment by Company

Xi'an Libang Pharmaceuticals

Xi'an Hanfeng Pharmaceuticals

Sun Pharma

Hemony Pharmaceutical

Sichuan Ren'an Pharmaceuticals

Novartis

Nanjing Haina Pharmaceutical

China Resources Double Crane Pharmaceuticals

Fuan Pharmaceutical Group

Chengdu Beite

Viatris

Jazz Pharmaceuicals

Hikma

GABAB Receptor Agonists Segment by Type

Baclofen

γ-hydroxybutyrate(GHB)）

GABAB Receptor Agonists Segment by Application

Hospital

Clinic

Other

GABAB Receptor Agonists Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABAB Receptor Agonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GABAB Receptor Agonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABAB Receptor Agonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the GABAB Receptor Agonists market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of GABAB Receptor Agonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of GABAB Receptor Agonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of GABAB Receptor Agonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. GABAB Receptor Agonists Industry Trends Table 2. GABAB Receptor Agonists Industry Drivers Table 3. GABAB Receptor Agonists Industry Opportunities and Challenges Table 4. GABAB Receptor Agonists Industry Restraints Table 5. Global GABAB Receptor Agonists Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global GABAB Receptor Agonists Revenue Market Share by Manufacturers (2021-2026) Table 7. Global GABAB Receptor Agonists Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global GABAB Receptor Agonists Sales Market Share by Manufacturers Table 9. Global GABAB Receptor Agonists Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global GABAB Receptor Agonists Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global GABAB Receptor Agonists Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global GABAB Receptor Agonists Manufacturers, Product Type & Application Table 13. Global GABAB Receptor Agonists Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global GABAB Receptor Agonists by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Baclofen Table 17. Major Manufacturers of γ-hydroxybutyrate(GHB)） Table 18. Global GABAB Receptor Agonists Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global GABAB Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 20. Global GABAB Receptor Agonists Sales by Type (2027-2032) & (K Units) Table 21. Global GABAB Receptor Agonists Sales Market Share by Type (2021-2026) Table 22. Global GABAB Receptor Agonists Sales Market Share by Type (2027-2032) Table 23. Global GABAB Receptor Agonists Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global GABAB Receptor Agonists Revenue by Type (2021-2026) & (K Units) Table 25. Global GABAB Receptor Agonists Revenue by Type (2027-2032) & (K Units) Table 26. Global GABAB Receptor Agonists Revenue Market Share by Type (2021-2026) Table 27. Global GABAB Receptor Agonists Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global GABAB Receptor Agonists Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global GABAB Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 33. Global GABAB Receptor Agonists Sales by Application (2027-2032) & (K Units) Table 34. Global GABAB Receptor Agonists Sales Market Share by Application (2021-2026) Table 35. Global GABAB Receptor Agonists Sales Market Share by Application (2027-2032) Table 36. Global GABAB Receptor Agonists Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global GABAB Receptor Agonists Revenue by Application (2021-2026) & (K Units) Table 38. Global GABAB Receptor Agonists Revenue by Application (2027-2032) & (K Units) Table 39. Global GABAB Receptor Agonists Revenue Market Share by Application (2021-2026) Table 40. Global GABAB Receptor Agonists Revenue Market Share by Application (2027-2032) Table 41. Global GABAB Receptor Agonists Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global GABAB Receptor Agonists Sales by Region (2021-2026) & (K Units) Table 43. Global GABAB Receptor Agonists Sales Market Share by Region (2021-2026) Table 44. Global GABAB Receptor Agonists Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global GABAB Receptor Agonists Sales Forecasted Market Share by Region (2027-2032) Table 46. North America GABAB Receptor Agonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America GABAB Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 48. North America GABAB Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 49. Europe GABAB Receptor Agonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe GABAB Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 51. Europe GABAB Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific GABAB Receptor Agonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific GABAB Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific GABAB Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa GABAB Receptor Agonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa GABAB Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa GABAB Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 58. Global GABAB Receptor Agonists Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global GABAB Receptor Agonists Revenue by Region (2021-2026) & (US$ Million) Table 60. Global GABAB Receptor Agonists Revenue by Region (2027-2032) & (US$ Million) Table 61. Global GABAB Receptor Agonists Revenue Market Share by Region (2021-2026) Table 62. Global GABAB Receptor Agonists Revenue Market Share by Region (2027-2032) Table 63. Xi'an Libang Pharmaceuticals Company Information Table 64. Xi'an Libang Pharmaceuticals Business Overview Table 65. Xi'an Libang Pharmaceuticals GABAB Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Xi'an Libang Pharmaceuticals GABAB Receptor Agonists Product Portfolio Table 67. Xi'an Libang Pharmaceuticals Recent Development Table 68. Xi'an Hanfeng Pharmaceuticals Company Information Table 69. Xi'an Hanfeng Pharmaceuticals Business Overview Table 70. Xi'an Hanfeng Pharmaceuticals GABAB Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Xi'an Hanfeng Pharmaceuticals GABAB Receptor Agonists Product Portfolio Table 72. Xi'an Hanfeng Pharmaceuticals Recent Development Table 73. Sun Pharma Company Information Table 74. Sun Pharma Business Overview Table 75. Sun Pharma GABAB Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sun Pharma GABAB Receptor Agonists Product Portfolio Table 77. Sun Pharma Recent Development Table 78. Hemony Pharmaceutical Company Information Table 79. Hemony Pharmaceutical Business Overview Table 80. Hemony Pharmaceutical GABAB Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Hemony Pharmaceutical GABAB Receptor Agonists Product Portfolio Table 82. Hemony Pharmaceutical Recent Development Table 83. Sichuan Ren'an Pharmaceuticals Company Information Table 84. Sichuan Ren'an Pharmaceuticals Business Overview Table 85. Sichuan Ren'an Pharmaceuticals GABAB Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sichuan Ren'an Pharmaceuticals GABAB Receptor Agonists Product Portfolio Table 87. Sichuan Ren'an Pharmaceuticals Recent Development Table 88. Novartis Company Information Table 89. Novartis Business Overview Table 90. Novartis GABAB Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Novartis GABAB Receptor Agonists Product Portfolio Table 92. Novartis Recent Development Table 93. Nanjing Haina Pharmaceutical Company Information Table 94. Nanjing Haina Pharmaceutical Business Overview Table 95. Nanjing Haina Pharmaceutical GABAB Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Nanjing Haina Pharmaceutical GABAB Receptor Agonists Product Portfolio Table 97. Nanjing Haina Pharmaceutical Recent Development Table 98. China Resources Double Crane Pharmaceuticals Company Information Table 99. China Resources Double Crane Pharmaceuticals Business Overview Table 100. China Resources Double Crane Pharmaceuticals GABAB Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. China Resources Double Crane Pharmaceuticals GABAB Receptor Agonists Product Portfolio Table 102. China Resources Double Crane Pharmaceuticals Recent Development Table 103. Fuan Pharmaceutical Group Company Information Table 104. Fuan Pharmaceutical Group Business Overview Table 105. Fuan Pharmaceutical Group GABAB Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Fuan Pharmaceutical Group GABAB Receptor Agonists Product Portfolio Table 107. Fuan Pharmaceutical Group Recent Development Table 108. Chengdu Beite Company Information Table 109. Chengdu Beite Business Overview Table 110. Chengdu Beite GABAB Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Chengdu Beite GABAB Receptor Agonists Product Portfolio Table 112. Chengdu Beite Recent Development Table 113. Viatris Company Information Table 114. Viatris Business Overview Table 115. Viatris GABAB Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Viatris GABAB Receptor Agonists Product Portfolio Table 117. Viatris Recent Development Table 118. Jazz Pharmaceuicals Company Information Table 119. Jazz Pharmaceuicals Business Overview Table 120. Jazz Pharmaceuicals GABAB Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Jazz Pharmaceuicals GABAB Receptor Agonists Product Portfolio Table 122. Jazz Pharmaceuicals Recent Development Table 123. Hikma Company Information Table 124. Hikma Business Overview Table 125. Hikma GABAB Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Hikma GABAB Receptor Agonists Product Portfolio Table 127. Hikma Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. GABAB Receptor Agonists Distributors List Table 131. GABAB Receptor Agonists Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. GABAB Receptor Agonists Product Image Figure 2. Global GABAB Receptor Agonists Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GABAB Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 4. Global GABAB Receptor Agonists Sales (2021-2032) & (K Units) Figure 5. Global GABAB Receptor Agonists Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 GABAB Receptor Agonists Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Baclofen Image Figure 9. γ-hydroxybutyrate(GHB)） Image Figure 10. Global GABAB Receptor Agonists Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global GABAB Receptor Agonists Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global GABAB Receptor Agonists Sales Market Share by Type (2021-2032) Figure 13. Global GABAB Receptor Agonists Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global GABAB Receptor Agonists Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global GABAB Receptor Agonists Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global GABAB Receptor Agonists Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global GABAB Receptor Agonists Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global GABAB Receptor Agonists Sales Market Share by Application (2021-2032) Figure 22. Global GABAB Receptor Agonists Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global GABAB Receptor Agonists Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global GABAB Receptor Agonists Revenue Market Share by Application (2021-2032) Figure 25. North America GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America GABAB Receptor Agonists Sales Market Share by Country (2021-2032) Figure 27. U.S. GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe GABAB Receptor Agonists Sales Market Share by Country (2021-2032) Figure 32. Germany GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific GABAB Receptor Agonists Sales Market Share by Country (2021-2032) Figure 39. China GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa GABAB Receptor Agonists Sales Market Share by Country (2021-2032) Figure 47. Brazil GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile GABAB Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global GABAB Receptor Agonists Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global GABAB Receptor Agonists Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Figure 58. North America GABAB Receptor Agonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Figure 60. Europe GABAB Receptor Agonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific GABAB Receptor Agonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa GABAB Receptor Agonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. GABAB Receptor Agonists Value Chain Figure 66. Manufacturing Cost Structure Figure 67. GABAB Receptor Agonists Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Baclofen
  • γ-hydroxybutyrate(GHB)）
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Xi'an Libang Pharmaceuticals
  • Xi'an Hanfeng Pharmaceuticals
  • Sun Pharma
  • Hemony Pharmaceutical
  • Sichuan Ren'an Pharmaceuticals
  • Novartis
  • Nanjing Haina Pharmaceutical
  • China Resources Double Crane Pharmaceuticals
  • Fuan Pharmaceutical Group
  • Chengdu Beite
  • Viatris
  • Jazz Pharmaceuicals
  • Hikma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global GABAB Receptor Agonists Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global GABAB Receptor Agonists Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global GABAB Receptor Agonists Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global GABAB Receptor Agonists Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global GABAB Receptor Agonists Market Dynamics
  1. 2.1 GABAB Receptor Agonists Industry Trends
  2. 2.2 GABAB Receptor Agonists Industry Drivers
  3. 2.3 GABAB Receptor Agonists Industry Opportunities and Challenges
  4. 2.4 GABAB Receptor Agonists Industry Restraints
3 GABAB Receptor Agonists Market by Manufacturers
  1. 3.1 Global GABAB Receptor Agonists Revenue by Manufacturers (2021-2026)
  2. 3.2 Global GABAB Receptor Agonists Sales by Manufacturers (2021-2026)
  3. 3.3 Global GABAB Receptor Agonists Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global GABAB Receptor Agonists Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global GABAB Receptor Agonists Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global GABAB Receptor Agonists Manufacturers, Product Type & Application
  7. 3.7 Global GABAB Receptor Agonists Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global GABAB Receptor Agonists Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 GABAB Receptor Agonists Players Market Share by Revenue in 2025
  11. 3.8.3 2025 GABAB Receptor Agonists Tier 1, Tier 2, and Tier 3
4 GABAB Receptor Agonists Market by Type
  1. 4.1 GABAB Receptor Agonists Type Introduction
  2. 4.1.1 Baclofen
  3. 4.1.2 γ-hydroxybutyrate(GHB)）
  4. 4.2 Global GABAB Receptor Agonists Sales by Type
  5. 4.2.1 Global GABAB Receptor Agonists Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global GABAB Receptor Agonists Sales by Type (2021-2032)
  7. 4.2.3 Global GABAB Receptor Agonists Sales Market Share by Type (2021-2032)
  8. 4.3 Global GABAB Receptor Agonists Revenue by Type
  9. 4.3.1 Global GABAB Receptor Agonists Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global GABAB Receptor Agonists Revenue by Type (2021-2032)
  11. 4.3.3 Global GABAB Receptor Agonists Revenue Market Share by Type (2021-2032)
5 GABAB Receptor Agonists Market by Application
  1. 5.1 GABAB Receptor Agonists Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global GABAB Receptor Agonists Sales by Application
  6. 5.2.1 Global GABAB Receptor Agonists Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global GABAB Receptor Agonists Sales by Application (2021-2032)
  8. 5.2.3 Global GABAB Receptor Agonists Sales Market Share by Application (2021-2032)
  9. 5.3 Global GABAB Receptor Agonists Revenue by Application
  10. 5.3.1 Global GABAB Receptor Agonists Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global GABAB Receptor Agonists Revenue by Application (2021-2032)
  12. 5.3.3 Global GABAB Receptor Agonists Revenue Market Share by Application (2021-2032)
6 Global GABAB Receptor Agonists Sales by Region
  1. 6.1 Global GABAB Receptor Agonists Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global GABAB Receptor Agonists Sales by Region (2021-2032)
  3. 6.2.1 Global GABAB Receptor Agonists Sales by Region (2021-2026)
  4. 6.2.2 Global GABAB Receptor Agonists Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America GABAB Receptor Agonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America GABAB Receptor Agonists Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe GABAB Receptor Agonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe GABAB Receptor Agonists Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific GABAB Receptor Agonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific GABAB Receptor Agonists Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa GABAB Receptor Agonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa GABAB Receptor Agonists Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global GABAB Receptor Agonists Revenue by Region
  1. 7.1 Global GABAB Receptor Agonists Revenue by Region
  2. 7.1.1 Global GABAB Receptor Agonists Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global GABAB Receptor Agonists Revenue by Region (2021-2026)
  4. 7.1.3 Global GABAB Receptor Agonists Revenue by Region (2027-2032)
  5. 7.1.4 Global GABAB Receptor Agonists Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America GABAB Receptor Agonists Revenue (2021-2032)
  8. 7.2.2 North America GABAB Receptor Agonists Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe GABAB Receptor Agonists Revenue (2021-2032)
  11. 7.3.2 Europe GABAB Receptor Agonists Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific GABAB Receptor Agonists Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific GABAB Receptor Agonists Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa GABAB Receptor Agonists Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa GABAB Receptor Agonists Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Xi'an Libang Pharmaceuticals
  2. 8.1.1 Xi'an Libang Pharmaceuticals Company Information
  3. 8.1.2 Xi'an Libang Pharmaceuticals Business Overview
  4. 8.1.3 Xi'an Libang Pharmaceuticals GABAB Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Xi'an Libang Pharmaceuticals GABAB Receptor Agonists Product Portfolio
  6. 8.1.5 Xi'an Libang Pharmaceuticals Recent Developments
  7. 8.2 Xi'an Hanfeng Pharmaceuticals
  8. 8.2.1 Xi'an Hanfeng Pharmaceuticals Company Information
  9. 8.2.2 Xi'an Hanfeng Pharmaceuticals Business Overview
  10. 8.2.3 Xi'an Hanfeng Pharmaceuticals GABAB Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Xi'an Hanfeng Pharmaceuticals GABAB Receptor Agonists Product Portfolio
  12. 8.2.5 Xi'an Hanfeng Pharmaceuticals Recent Developments
  13. 8.3 Sun Pharma
  14. 8.3.1 Sun Pharma Company Information
  15. 8.3.2 Sun Pharma Business Overview
  16. 8.3.3 Sun Pharma GABAB Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharma GABAB Receptor Agonists Product Portfolio
  18. 8.3.5 Sun Pharma Recent Developments
  19. 8.4 Hemony Pharmaceutical
  20. 8.4.1 Hemony Pharmaceutical Company Information
  21. 8.4.2 Hemony Pharmaceutical Business Overview
  22. 8.4.3 Hemony Pharmaceutical GABAB Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hemony Pharmaceutical GABAB Receptor Agonists Product Portfolio
  24. 8.4.5 Hemony Pharmaceutical Recent Developments
  25. 8.5 Sichuan Ren'an Pharmaceuticals
  26. 8.5.1 Sichuan Ren'an Pharmaceuticals Company Information
  27. 8.5.2 Sichuan Ren'an Pharmaceuticals Business Overview
  28. 8.5.3 Sichuan Ren'an Pharmaceuticals GABAB Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sichuan Ren'an Pharmaceuticals GABAB Receptor Agonists Product Portfolio
  30. 8.5.5 Sichuan Ren'an Pharmaceuticals Recent Developments
  31. 8.6 Novartis
  32. 8.6.1 Novartis Company Information
  33. 8.6.2 Novartis Business Overview
  34. 8.6.3 Novartis GABAB Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novartis GABAB Receptor Agonists Product Portfolio
  36. 8.6.5 Novartis Recent Developments
  37. 8.7 Nanjing Haina Pharmaceutical
  38. 8.7.1 Nanjing Haina Pharmaceutical Company Information
  39. 8.7.2 Nanjing Haina Pharmaceutical Business Overview
  40. 8.7.3 Nanjing Haina Pharmaceutical GABAB Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nanjing Haina Pharmaceutical GABAB Receptor Agonists Product Portfolio
  42. 8.7.5 Nanjing Haina Pharmaceutical Recent Developments
  43. 8.8 China Resources Double Crane Pharmaceuticals
  44. 8.8.1 China Resources Double Crane Pharmaceuticals Company Information
  45. 8.8.2 China Resources Double Crane Pharmaceuticals Business Overview
  46. 8.8.3 China Resources Double Crane Pharmaceuticals GABAB Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 China Resources Double Crane Pharmaceuticals GABAB Receptor Agonists Product Portfolio
  48. 8.8.5 China Resources Double Crane Pharmaceuticals Recent Developments
  49. 8.9 Fuan Pharmaceutical Group
  50. 8.9.1 Fuan Pharmaceutical Group Company Information
  51. 8.9.2 Fuan Pharmaceutical Group Business Overview
  52. 8.9.3 Fuan Pharmaceutical Group GABAB Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Fuan Pharmaceutical Group GABAB Receptor Agonists Product Portfolio
  54. 8.9.5 Fuan Pharmaceutical Group Recent Developments
  55. 8.10 Chengdu Beite
  56. 8.10.1 Chengdu Beite Company Information
  57. 8.10.2 Chengdu Beite Business Overview
  58. 8.10.3 Chengdu Beite GABAB Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Chengdu Beite GABAB Receptor Agonists Product Portfolio
  60. 8.10.5 Chengdu Beite Recent Developments
  61. 8.11 Viatris
  62. 8.11.1 Viatris Company Information
  63. 8.11.2 Viatris Business Overview
  64. 8.11.3 Viatris GABAB Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Viatris GABAB Receptor Agonists Product Portfolio
  66. 8.11.5 Viatris Recent Developments
  67. 8.12 Jazz Pharmaceuicals
  68. 8.12.1 Jazz Pharmaceuicals Company Information
  69. 8.12.2 Jazz Pharmaceuicals Business Overview
  70. 8.12.3 Jazz Pharmaceuicals GABAB Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Jazz Pharmaceuicals GABAB Receptor Agonists Product Portfolio
  72. 8.12.5 Jazz Pharmaceuicals Recent Developments
  73. 8.13 Hikma
  74. 8.13.1 Hikma Company Information
  75. 8.13.2 Hikma Business Overview
  76. 8.13.3 Hikma GABAB Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hikma GABAB Receptor Agonists Product Portfolio
  78. 8.13.5 Hikma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 GABAB Receptor Agonists Value Chain Analysis
  2. 9.1.1 GABAB Receptor Agonists Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 GABAB Receptor Agonists Production Mode & Process
  6. 9.2 GABAB Receptor Agonists Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 GABAB Receptor Agonists Distributors
  9. 9.2.3 GABAB Receptor Agonists Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst